Novartis division resubmits USFDA application for biosimilar Pegfilgrastim Farhat Nasim4 April 2019 9:15 AM ISTNew Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...
GSK reports positive data from trial of cancer drug Dostarlimab Garima21 March 2019 9:15 AM ISTGSK said it would apply for marketing approval for Dostarlimab in endometrial cancer at the end of 2019.New Delhi: GlaxoSmithKline said on Tuesday a...
Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 9:30 AM ISTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
Loxo-Bayer cancer drug gets priority review from FDA Ruby Khatun Khatun1 Jun 2018 9:30 AM ISTLoxo Oncology and Bayer AG said the U.S. Food and Drug Administration granted priority review to their cancer drug and would decide on the marketing...
Roche plea in HC on cancer drug not maintainable: Biocon, Mylan Ruby Khatun Khatun12 Jan 2018 10:27 AM ISTNew Delhi: Generic drug makers Biocon and Mylan told the Delhi High Court that Swiss pharma major Roche's civil suit, challenging DCGI approvals...
Panacea Biotec gets USFDA nod to file for generic cancer drug Ruby Khatun Khatun2 Dec 2017 10:00 AM ISTNew Delhi: Panacea Biotec said the US health regulator has accepted its filing for approval of generic version of cancer treatment injection...
Roche sues Pfizer to bar biosimilar of cancer drug Herceptin Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTRoche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block...
FDA expands approval for Pfizer cancer drug Studnt Ruby Khatun Khatun20 Nov 2017 10:07 AM ISTThe U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
Novartis posts eye drug data amid play for Eylea's turf Ruby Khatun Khatun14 Nov 2017 9:45 AM ISTZURICH: Novartis's bid to move in on Bayer's and Regeneron's eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker's new...
Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
Blockbuster cancer drug Keytruda launched in India Ruby Khatun Khatun14 Sept 2017 11:29 AM ISTNew Delhi: US-based drug major MSD said it has launched cancer drug Keytruda in India for treatment of advanced melanoma, a form of skin cancer.The...
